sorafenib has been researched along with Eosinophilia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brendehaug, A; Eek, AK; Forthun, RB; Hovland, R; Høysæter, T; Munthe-Kaas, MC; Osnes, LTN; Prescott, T; Spetalen, S | 1 |
| Falchi, L; Lu, G; Luthra, R; Lyle, LM; Mehrotra, M; Newberry, KJ; Patel, KP; Popat, U; Verstovsek, S | 1 |
| Bloor, A; Cross, NC; Erben, P; Gesk, S; Haferlach, C; Haferlach, T; Hochhaus, A; Hofmann, WK; Metzgeroth, G; Reiter, A; Ritter, M; Score, J; Telford, N; Walz, C | 1 |
3 other study(ies) available for sorafenib and Eosinophilia
| Article | Year |
|---|---|
Partial Response to Sorafenib in a Child With a Myeloid/Lymphoid Neoplasm, Eosinophilia, and a ZMYM2-FLT3 Fusion.
Topics: Antineoplastic Agents; Child, Preschool; Eosinophilia; fms-Like Tyrosine Kinase 3; Humans; Lymphoma; Male; Nuclear Proteins; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Sorafenib | 2021 |
ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant.
Topics: Adult; Cytogenetics; Eosinophilia; ETS Translocation Variant 6 Protein; Female; fms-Like Tyrosine Kinase 3; Humans; Mutation; Myeloproliferative Disorders; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-ets; Repressor Proteins; Sorafenib; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2014 |
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3.
Topics: Adult; Amino Acid Sequence; Antineoplastic Agents; Base Sequence; Benzenesulfonates; DNA, Neoplasm; Drug Resistance, Neoplasm; Eosinophilia; ETS Translocation Variant 6 Protein; fms-Like Tyrosine Kinase 3; Hematologic Neoplasms; Humans; Indoles; Male; Middle Aged; Molecular Sequence Data; Niacinamide; Oncogene Fusion; Oncogene Proteins, Fusion; Phenylurea Compounds; Point Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ets; Pyridines; Pyrroles; Repressor Proteins; Sorafenib; Sunitinib | 2011 |